Annual CAPEX
N/A
31 December 2023
Summary:
Corbus Pharmaceuticals Holdings annual capital expenditures is not available.CRBP CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings quarterly capital expenditures is not available.CRBP Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings TTM capital expenditures is not available.CRBP TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBP CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
CRBP CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
Corbus Pharmaceuticals Holdings CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $54.20 K(-88.8%) | - | - |
Dec 2020 | $484.50 K(-82.3%) | -$52.10 K(-191.7%) | $484.50 K(-73.5%) |
Sept 2020 | - | $56.80 K(+250.6%) | $1.83 M(-38.4%) |
June 2020 | - | $16.20 K(-96.5%) | $2.97 M(-5.3%) |
Mar 2020 | - | $463.60 K(-64.1%) | $3.13 M(+14.2%) |
Dec 2019 | $2.74 M(+19.2%) | $1.29 M(+8.1%) | $2.74 M(+61.2%) |
Sept 2019 | - | $1.19 M(+551.5%) | $1.70 M(+177.7%) |
June 2019 | - | $183.30 K(+149.0%) | $612.50 K(-44.5%) |
Mar 2019 | - | $73.60 K(-70.5%) | $1.10 M(-52.0%) |
Dec 2018 | $2.30 M | $249.80 K(+136.1%) | $2.30 M(-12.6%) |
Sept 2018 | - | $105.80 K(-84.3%) | $2.63 M(+2.3%) |
June 2018 | - | $675.20 K(-46.8%) | $2.57 M(+32.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | $1.27 M(+118.8%) | $1.94 M(+173.8%) |
Dec 2017 | $707.40 K(+100.4%) | $580.20 K(+1178.0%) | $707.40 K(+216.9%) |
Sept 2017 | - | $45.40 K(+8.9%) | $223.20 K(-9.9%) |
June 2017 | - | $41.70 K(+4.0%) | $247.70 K(-24.4%) |
Mar 2017 | - | $40.10 K(-58.2%) | $327.80 K(-7.1%) |
Dec 2016 | $353.00 K(+209.6%) | $96.00 K(+37.3%) | $353.00 K(+0.9%) |
Sept 2016 | - | $69.90 K(-42.6%) | $350.00 K(+22.9%) |
June 2016 | - | $121.80 K(+86.5%) | $284.90 K(+60.4%) |
Mar 2016 | - | $65.30 K(-29.8%) | $177.60 K(+58.1%) |
Dec 2015 | $114.00 K | $93.00 K(+1837.5%) | $112.30 K(+481.9%) |
Sept 2015 | - | $4800.00(-66.9%) | $19.30 K(+33.1%) |
June 2015 | - | $14.50 K | $14.50 K |
FAQ
- What is the all time high annual CAPEX for Corbus Pharmaceuticals Holdings?
- What is the all time high quarterly CAPEX for Corbus Pharmaceuticals Holdings?
- What is the all time high TTM CAPEX for Corbus Pharmaceuticals Holdings?
What is the all time high annual CAPEX for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual capital expenditures is $2.74 M
What is the all time high quarterly CAPEX for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly capital expenditures is $1.29 M
What is the all time high TTM CAPEX for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM capital expenditures is $3.13 M